Aardvark’s lead candidate ARD-101 is being investigated in a Phase III study for hyperphagia in Prader-Willi syndrome.

Cybersecurity company SailPoint opened for trading on Thursday, returning to the markets more than two years after it went private.Maximize ...

Marvin Slosman, Chief Executive Officer of InspireMD, commented, “With more than 30,000 TCAR procedures performed in the U.S. each year, TCAR is a rapidly growing procedure that represents a ...

Wednesday marks the opening day of the 2025 West Virginia Legislative Session, and the day will end with Governor Patrick ...

Türkiye High Level Strategic Cooperation Council in a joint declaration after its 7th session on Thursday pledged to further ...

President Donald Trump is set to announce "reciprocal" tariffs of countries around the globe Thursday. Follow Newsweek's live ...

The company’s quantum solutions are used in scheduling, mobility, logistics, drug discovery, portfolio optimization, manufacturing processes, and other. D-Wave Quantum Inc. was founded in 1999 ...

AEON Biopharma, Inc. (NYSE: AEON) (the "Company"), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) ...

DeepSeek has triggered a wave of artificial intelligence (AI) deployments across China's hi-tech manufacturing sector - ...

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.